FDA authorizes Remdesivir drug for COVID-19

FDA authorizes Remdesivir drug for COVID-19

Reuters

Published

President Donald Trump said on Friday the U.S. Food and Drug Administration (FDA) had granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug Remdesivir to treat patients with COVID-19.

Full Article